Corcept Therapeutics (CORT) Interest Coverage Ratio Growth (3y) (2013 - 2017)
Powered by 
Analysis
Corcept Therapeutics (CORT) Interest Coverage Ratio Growth (3y) (2013 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -44.22% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -35.50% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 81.16% |
| 10 | Corcept Therapeutics | 11.76 Bn | 11.46 Bn | 252.09 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | 177.04% |
| Mar 31, 2017 | 55.43% |
| Dec 31, 2016 | 49.36% |
| Sep 30, 2016 | 40.19% |
| Jun 30, 2016 | 31.87% |
| Mar 31, 2016 | 28.08% |
| Dec 31, 2015 | 31.49% |
| Sep 30, 2015 | 26.24% |
| Jun 30, 2015 | 90.01% |
| Mar 31, 2015 | 86.83% |
| Dec 31, 2014 | 85.53% |
| Sep 30, 2014 | 90.42% |
| Jun 30, 2014 | 79.07% |
| Mar 31, 2014 | 79.63% |
| Dec 31, 2013 | 79.83% |
| Sep 30, 2013 | 84.78% |
| Jun 30, 2013 | 83.48% |